Downey Gregory 4
4 · Lexaria Bioscience Corp. · Filed Jun 9, 2021
Insider Transaction Report
Form 4
Downey Gregory
Chief Financial Officer
Transactions
- Award
Stock Options
2021-06-08+8,000→ 25,000 totalExercise: $7.08From: 2021-06-08Exp: 2026-06-08→ Common Shares (8,000 underlying)
Holdings
- 12,000
Stock Options
Exercise: $5.04From: 2023-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying) - 4,000
Stock Options
Exercise: $5.04From: 2021-04-15Exp: 2026-04-26→ Common Shares (4,000 underlying) - 8,000
Stock Options
Exercise: $5.04From: 2022-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying) - 1,833
common shares
- 17,000
Stock Options
Exercise: $5.31From: 2022-04-26Exp: 2026-04-26→ Common Shares (5,000 underlying)